SGP · SpyGlass Pharma, Inc. Common Stock

Summary

On February 12, 2026, the Compensation Committee approved performance cash bonuses for Named Executive Officers for Fiscal Year 2025. The filing discloses updated total compensation figures for 2025, including $3,322,711 for CEO Patrick Mooney, $2,484,469 for President Malik Y. Kahook, and $1,539,952 for Chief R&D Officer Chetan Pujara.

Key takeaways

• Compensation Committee approved Fiscal Year 2025 performance cash bonuses on February 12, 2026.
• CEO Patrick Mooney's 2025 total compensation was $3,322,711, including a $215,088 non-equity incentive bonus.
• President and Chief Medical Officer Malik Y. Kahook's 2025 total compensation was $2,484,469.
• Chief Research & Development Officer Chetan Pujara's 2025 total compensation was $1,539,952.
• Dr. Pujara commenced employment with the Company in February 2025.